Home > Insider Trading > Filing (0001415889-23-005807)

Filing Details

Accession Number:: 0001415889-23-005807
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-04-03 16:51:33
Reporting Period:: 2023-03-31

Accepted Time:: 2023-04-03 16:51:33
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1082554	United Therapeutics Corp	UTHR	Pharmaceutical Preparations (2834)	521984749

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1106578	A Martine Rothblatt	C/O United Therapeutics Corporation 1040 Spring Street Silver Spring MD 20910	Chairperson & Ceo	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2023-03-31	8,000	$113.08	8,130	No	4	M	Direct
Common Stock	Disposition	2023-03-31	1,040	$218.94	7,090	No	4	S	Direct
Common Stock	Disposition	2023-03-31	1,906	$220.04	5,184	No	4	S	Direct
Common Stock	Disposition	2023-03-31	861	$222.12	4,323	No	4	S	Direct
Common Stock	Disposition	2023-03-31	1,873	$223.22	2,450	No	4	S	Direct
Common Stock	Disposition	2023-03-31	1,087	$223.88	1,363	No	4	S	Direct
Common Stock	Disposition	2023-03-31	1,233	$220.93	130	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options	Disposition	2023-03-31	8,000	$0.00	8,000	$113.08

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
168,000	2013-12-31	2023-12-31	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	166	Indirect	By Spouse
Common Stock	644,183	Indirect	By Trusts

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Options	$120.26	2017-03-15	2026-03-15	294,000	294,000	Indirect
Common Stock	Stock Options	$146.03	2018-03-15	2027-03-15	240,000	240,000	Indirect
Common Stock	Stock Options	$146.03	2020-03-15	2027-03-15	100,000	100,000	Indirect
Common Stock	Stock Options	$146.03	2020-03-15	2027-03-15	244,122	244,122	Indirect
Common Stock	Stock Options	$146.03	2018-03-15	2027-03-15	150,288	150,288	Indirect
Common Stock	Stock Options	$111.00	2021-03-15	2028-03-15	285,103	285,103	Indirect
Common Stock	Stock Options	$111.00	2019-03-15	2028-03-15	213,827	213,827	Indirect
Common Stock	Stock Options	$135.42	2023-03-15	2027-03-15	500,000	500,000	Indirect
Common Stock	Stock Options	$117.76	2021-03-15	2027-03-15	500,000	500,000	Indirect

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2026-03-15	294,000	294,000	Indirect
2027-03-15	240,000	240,000	Indirect
2027-03-15	100,000	100,000	Indirect
2027-03-15	244,122	244,122	Indirect
2027-03-15	150,288	150,288	Indirect
2028-03-15	285,103	285,103	Indirect
2028-03-15	213,827	213,827	Indirect
2027-03-15	500,000	500,000	Indirect
2027-03-15	500,000	500,000	Indirect

Footnotes

This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a) exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023.
This transaction was executed in multiple trades at prices ranging from $218.44 to $219.305. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $219.455 to $220.43. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $221.595 to $222.565. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $222.605 to $223.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $223.61 to $224.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $220.465 to $221.44. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This stock option was transferred to a trust beneficially owned by the reporting person on March 31, 2023.